Research map: Hirudin Attenuates Uric Acid‐Induced Renal Tubular Injury via TNFRSF6B ‐Mediated Suppression of NF ‐ κB Signaling

Back to the article

Papers in this map

  1. Signaling to NF-κB by Toll-like receptors · Taro Kawai · 2007 · 2422 citations · Cited by this paper
  2. Using a N ano BRET ‐Based Ligand‐Binding Assay at the β 2 ‐Adrenoceptor for Undergraduate Pharmacology Education · 2026 · Related
  3. Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study · Hui Yu · 2020 · 2186 citations · Cited by this paper
  4. Magnitude, Preventability, and Determinants of Adverse Drug Reactions Among Hospitalized Obstetric Patients in Ethiopia: A Prospective Observational Study · 2026 · Related
  5. Hyperuricemia and its related diseases: mechanisms and advances in therapy · Lin Du · 2024 · 618 citations · Cited by this paper
  6. Potent and Sustained Lowering of Serum Uric Acid by YJH ‐012‐D, a G al NA c‐Conjugated si RNA Targeting Xanthine Dehydrogenase · 2026 · Related
  7. Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease · Hidekatsu Yanai · 2021 · 602 citations · Cited by this paper
  8. A Prospective Study of Marsh PK ‐ PD Model and Schnider PK ‐ PD Model During Anesthesia Induction for Obese Patients Undergoing Elective Heart Surgery · 2026 · Related
  9. Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment · Mihai-Emil Gherghina · 2022 · 506 citations · Cited by this paper
  10. Reported Characteristics of Anaphylaxis Associated With Glatiramer Acetate: A Pharmacovigilance Analysis of the FDA and Canadian Databases · 2026 · Related
  11. An update on the genetics of hyperuricaemia and gout · Tanya J. Major · 2018 · 342 citations · Cited by this paper
  12. Deciphering the Functional Mechanisms of eIF3f in Tumors and Exploring Targeted Therapies · 2026 · Related
  13. Asymptomatic hyperuricaemia: a silent activator of the innate immune system · Leo A. B. Joosten · 2019 · 328 citations · Cited by this paper
  14. A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Highly Selective NaV1.8 Inhibitor JKN2306 in Healthy Chinese Subjects · 2026 · Related
  15. Assessing the Causal Relationships Between Insulin Resistance and Hyperuricemia and Gout Using Bidirectional Mendelian Randomization · Natalie McCormick · 2021 · 179 citations · Cited by this paper
  16. Student and Graduate Perceptions of Their Development of the Core Attitudes From the British Pharmacological Society's Undergraduate Pharmacology Curriculum · 2026 · Related
  17. Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer · Wan‐Wan Lin · 2011 · 155 citations · Cited by this paper
  18. Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education · 2026 · Related
  19. The protective effect of quercetin on macrophage pyroptosis via TLR2/Myd88/NF-κB and ROS/AMPK pathway · Xing Luo · 2021 · 153 citations · Cited by this paper
  20. Impact of FCGR2A and FCGR3A Gene Variants on the Response to Rituximab in Patients With Glomerular Diseases · 2026 · Related
  21. Asymptomatic hyperuricemia: is it really asymptomatic? · Kevin Hak-Kong Yip · 2019 · 151 citations · Cited by this paper
  22. High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling · De Xie · 2021 · 147 citations · Cited by this paper
  23. Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy · Yingfeng Shi · 2020 · 130 citations · Cited by this paper
  24. Coptisine protects against hyperuricemic nephropathy through alleviating inflammation, oxidative stress and mitochondrial apoptosis via PI3K/Akt signaling pathway · Yanlu Liu · 2022 · 117 citations · Cited by this paper
  25. The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications · Delun Li · 2023 · 113 citations · Cited by this paper
  26. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions · Shie-Liang Edmond Hsieh · 2017 · 106 citations · Cited by this paper
  27. Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine/dimethylarginine dimethylaminotransferase 2 pathway · Tzong‐Shyuan Lee · 2021 · 106 citations · Cited by this paper
  28. Pyroptosis in renal inflammation and fibrosis: current knowledge and clinical significance · Ya Liu · 2023 · 79 citations · Cited by this paper
  29. Punicalagin attenuates hyperuricemia via restoring hyperuricemia-induced renal and intestinal dysfunctions · Qingqing Han · 2024 · 72 citations · Cited by this paper
  30. Fucoidan from Laminaria japonica Inhibits Expression of GLUT9 and URAT1 via PI3K/Akt, JNK and NF-κB Pathways in Uric Acid-Exposed HK-2 Cells · Yu Zhang · 2021 · 62 citations · Cited by this paper
  31. Phloretin attenuates hyperuricemia‐induced endothelial dysfunction through co‐inhibiting inflammation and GLUT 9‐mediated uric acid uptake · Shuyun Liu · 2017 · 60 citations · Cited by this paper
  32. The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy · Hongtu Hu · 2024 · 47 citations · Cited by this paper
  33. Simiao San alleviates hyperuricemia and kidney inflammation by inhibiting NLRP3 inflammasome and JAK2/STAT3 signaling in hyperuricemia mice · Yueyi Zhang · 2023 · 41 citations · Cited by this paper
  34. Decoy receptor 3 promotes cell adhesion and enhances endometriosis development · Hsiao‐Wen Tsai · 2017 · 34 citations · Cited by this paper
  35. Exercise and hyperuricemia: an opinion article · Ting Zhang · 2024 · 33 citations · Cited by this paper
  36. Pharmacology of Recombinant Hirudin · G Nowak · 2002 · 32 citations · Cited by this paper
  37. Linarin attenuates hyperuricemic nephropathy by modulating Nrf2/Keap1 and TLR4/NF-κB signaling pathways · Yongshuai Qian · 2025 · 30 citations · Cited by this paper
  38. Hirudin variants production by genetic engineered microbial factory · Jianguo Zhang · 2018 · 28 citations · Cited by this paper
  39. Asymptomatic hyperuricemia: to treat or not a threat? A clinical and evidence-based approach to the management of hyperuricemia in the context of cardiovascular diseases · Emiliano Fiori · 2024 · 26 citations · Cited by this paper

Source: OpenAlex (CC0)